Psychedelics
Biopharmaceutical company administers optimized form of LSD in Phase 2b dose-optimization trial
Hi, what are you looking for?
Mugglehead Investment Magazine
Psychedelics
Psychedelics
New York law firm forms multidisciplinary association intended to serve the psychedelic industry
Cannabis
New license is the final required step before administering doses to study participants
Business
COO Kevin Nicholson was appointed as the new CEO
Canada
Vancouver producer to supply synthetic psychedelic compounds to designated investigators and companies
Psychedelics
Multi-disciplinary controlled substance company set to commence operations at Calgary facility
Culture
Upcoming event said to feature powerful female speakers from broad cross-section of practices and expertise
Canada
The company and Hartle will host a virtual press conference scheduled for Wednesday at 1 pm
Canada
Biotechnology company will supply InterVivo and clients with clinical-grade MDMA for scientific analyses
Psychedelics
New clients offer detailed enthusiastic feedback thus far
